Skip to main content

IBM Common Licensing EUVDEUVD-2026-83136

| CVE-2026-1029 MEDIUM
Cross-site Scripting (XSS) (CWE-79)
2026-09-18 ibm GHSA-hgr9-85h8-464w
5.4
CVSS 3.1 · Vendor: ibm
Share

Severity by source

Vendor (ibm) PRIMARY
5.4 MEDIUM
AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
vuln.today AI
5.4 MEDIUM

Authenticated Web UI user injects script (PR:L), a victim must render it (UI:R), script runs cross-context (S:C) with limited confidentiality/integrity impact and no availability effect.

3.1 AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
4.0 AV:N/AC:L/AT:N/PR:L/UI:A/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N

Primary rating from Vendor (ibm).

CVSS VectorVendor: ibm

Attack Vector
Network
Attack Complexity
Low
Privileges Required
Low
User Interaction
Required
Scope
Changed
Confidentiality
Low
Integrity
Low
Availability
None

Lifecycle Timeline

1
Analysis Generated
Sep 18, 2026 - 16:23 vuln.today

DescriptionCVE.org

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

AnalysisAI

Cross-site scripting in IBM Common Licensing Agent and ART versions 9.0, 9.0.0.1, and 9.0.0.2 allows a user who already holds a low-privilege account on the licensing Web UI (PR:L) to embed arbitrary JavaScript that executes in another user's trusted session when that victim loads the tainted page (UI:R), potentially disclosing credentials or other session data. The flaw is rated CVSS 3.1 5.4 (AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N) and carries CWE-79; exploitation is limited to authenticated attackers and depends on a victim viewing the affected content, so it is not remotely exploitable without credentials or user interaction. …

Unlock full vulnerability intelligence

  • Risk assessment & exploitation conditions
  • Attack chain visualization
  • Remediation with exact patch versions
  • Threat intelligence from 22 sources
  • Personal watchlist & email alerts

Free forever · No credit card required

Attack ChainAIDerived

Hypothetical attack flow derived from CVE metadata

Access
technique details hidden
Delivery
technique details hidden
Exploit
technique details hidden
Execution
technique details hidden
Impact
technique details hidden

Vulnerability AssessmentAI

Exploitation Requires an authenticated session to the IBM Common Licensing / ART Web UI (PR:L) to inject the JavaScript payload, and requires a second user to load the affected page (UI:R) for the script to execute in their trusted session. … Additional conditions and limiting factors are described in the full assessment.
Risk Assessment This is a moderate-severity stored/reflected cross-site scripting flaw (CWE-79) with a vendor CVSS 3.1 of 5.4 (AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N). … Full risk analysis with EPSS, KEV, and SSVC signal comparison available after sign-in.
Exploit Scenario Full exploit scenario with step-by-step reproduction available after sign-in.
Remediation Apply the vendor patch for IBM Common Licensing Agent/ART as described in IBM's advisory at https://www.ibm.com/support/pages/node/7286490 (patch available per vendor advisory; the advisory is the authoritative source for the exact fixed build for each 9.0.x level, so confirm the corrected level there before upgrading). … Detailed patch versions, workarounds, and compensating controls in full report.

Threat intelligence, references, and detailed analysis are available after sign-in.

CVE-2025-15399 CRITICAL
10.0 Sep 18

Cross-site request forgery in IBM Common Licensing Agent and ART 9.0.x allows remote attackers to execute unauthorized a

CVE-2026-19646 CRITICAL
9.1 Sep 10

Done. The JSON synthesis is above. Summary of the analysis: - **What it is:** An open redirect / HTTP Host header injec

CVE-2024-40697 HIGH
7.5 Aug 13

IBM Common Licensing 9.0 does not require that users should have strong passwords by default, which makes it easier for

CVE-2023-50946 MEDIUM
6.5 Jan 26

IBM Common Licensing 9.0 could allow an authenticated user to modify a configuration file that they should not have acce

CVE-2026-19543 MEDIUM
6.2 Sep 14

IBM Common Licensing Agent and ART versions 9.0 through 9.0.0.2 enforce input validation only on the client side, leavin

CVE-2023-50945 MEDIUM
6.2 Jan 26

IBM Common Licensing 9.0 stores user credentials in plain clear text which can be read by a local user. Rated medium sev

CVE-2026-1031 MEDIUM
6.1 Sep 18

Cross-site scripting in the IBM Common Licensing Agent and ART Web UI (9.0, 9.0.0.1, 9.0.0.2) lets an unauthenticated at

CVE-2026-1025 MEDIUM
6.1 Sep 18

Cross-site scripting in IBM Common Licensing Agent 9.0 through 9.0.0.2 and ART 9.0 through 9.0.0.2 lets remote, unauthen

CVE-2026-1037 MEDIUM
6.1 Sep 18

Cross-site scripting (XSS) in the IBM Common Licensing Agent (9.0, 9.0.0.1, 9.0.0.2) and IBM ART (9.0, 9.0.0.1, 9.0.0.2)

CVE-2024-41774 MEDIUM
4.8 Aug 13

IBM Common Licensing 9.0 is vulnerable to stored cross-site scripting. Rated medium severity (CVSS 4.8), this vulnerabil

CVE-2026-1030 MEDIUM
4.3 Sep 18

Sensitive information exposure in IBM Common Licensing Agent 9.0 through 9.0.0.2 and IBM Administration and Reporting To

Share

EUVD-2026-83136 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy